<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">ACES</journal-id><journal-title-group><journal-title>Advances in Chemical Engineering and Science</journal-title></journal-title-group><issn pub-type="epub">2160-0392</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/aces.2012.22028</article-id><article-id pub-id-type="publisher-id">ACES-18898</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Chemistry&amp;Materials Science</subject></subj-group></article-categories><title-group><article-title>
 
 
  Oxidative Consumption of Oral Biomolecules by Therapeutically-Relevant Doses of Ozone
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>artin</surname><given-names>Grootveld</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Hubert</surname><given-names>Chang</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Martin</surname><given-names>Grootveld</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff2"><addr-line>83 Chambers Lane, Willesden Green, London NW10 2RN, UK</addr-line></aff><aff id="aff1"><addr-line>Warwick Dentistry, Warwick Medical School, University of Warwick, Warwick, UK</addr-line></aff><author-notes><corresp id="cor1">* E-mail:<email>mg6@bolton.ac.uk(AG)</email>;</corresp></author-notes><pub-date pub-type="epub"><day>27</day><month>04</month><year>2012</year></pub-date><volume>02</volume><issue>02</issue><fpage>238</fpage><lpage>245</lpage><history><date date-type="received"><day>October</day>	<month>23,</month>	<year>2011</year></date><date date-type="rev-recd"><day>January</day>	<month>4,</month>	<year>2012</year>	</date><date date-type="accepted"><day>February</day>	<month>5,</month>	<year>2012</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  In view of its potent microbicidal actions, ozone (O
  <sub>3</sub>) offers much potential for application as a therapeutic agent in oral health, e.g. in the treatment of dental caries. This oxidant is extremely reactive towards biomolecules present in the oral environment, and in this study we have employed high-resolution proton (
  <sup>1</sup>H) nuclear magnetic resonance (NMR) spectroscopy to determine the nature and extent of the oxidation of biomolecules known to be present in carious dentin, plaque and saliva. Phosphate-buffered (pH 7.00) aqueous solutions containing sodium pyruvate, 
  α-D-glucose, L-cys teine and L-methionine (5.00 mM) were treated with gaseous O
  <sub>3</sub> (4.48 mmol.) delivered by a therapeutic O
  <sub>3</sub> generating device. Attack of O
  <sub>3</sub> on methionine and cysteine generated the corresponding primary oxidation products of these substrates, specifically methionine sulphoxide [98% &#177; 4% (mean &#177; SEM) yield] and cystine (95% &#177; 6% yield) respectively, and treatment of pyruvate with this oxidant produced acetate and CO
  <sub>2</sub> via an oxidative decarboxylation process (93% &#177; 4% yield). Reaction of O
  <sub>3</sub> with 
  α-D-glucose gave rise to formate as a major product (24% &#177; 2% yield). In conclusion, multicomponent 
  <sup>1</sup>H NMR analysis of appropriate chemical model systems provides valuable molecular information regarding the reactivity of O
  <sub>3</sub> towards biomolecules present in the oral environment, information which is of much relevance to its therapeutic mechanisms of action. Moreover, in view of the much higher concentrations of these O
  <sub>3</sub>-scavenging biomolecules in oral fluid and/or soft tissue environments than that of O
  <sub>3</sub> applied, they may also serve to offer protection against putative adverse effects inducible by any of this oxidant which escapes from its site of therapeutic application (e.g., at primary root carious lesions).
 
</p></abstract><kwd-group><kwd>Ozone Therapy; Ozone Scavengers; Oral Biomolecules; Oral Fluids and Tissues; 1H NMR Analysis</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Currently, root caries represents a challenging problem to the dental profession in view of a marked increase in the population of elderly patients during the late 20th century. This condition is primarily ascribable to tooth demineralisation processes induced by organic acids (e.g., lactic, pyruvic and further organic acids) generated by bacteria, predominantly Streptococcus mutans [1-3], and recent investigations conducted by Baysan et al. [4-6] have revealed that ozone (O<sub>3</sub>) exerts powerful bactericidal actions towards this and other pathogens, together with further micro-organisms associated with primary root carious lesions. Indeed, the application of O<sub>3</sub> in dental practices may serve as a viable, cost-effective and convenient means of treating dental caries, and it may have the potential to eventually replace conventional drilling and filling procedures which are commonly and frequently employed by dental surgeons [<xref ref-type="bibr" rid="scirp.18898-ref7">7</xref>].</p><p>In view of its powerful oxidising actions, O<sub>3</sub> has a very extensive redox chemistry in physiological environments, and the oxidation of critical biomolecules is undoubtedly responsible for its broad-spectrum biocidal properties. Indeed, O<sub>3</sub> can attack a very wide variety of biomolecules, for example, free or protein-incorporated amino acids such as cysteine, methionine, tryptophan, histidine and tyrosine, carbohydrates such as glucose, amines such as trimethylamine, phenolic adducts, ascorbate and urate [8,9], and, of course, its well-characterised ozonation of carbon-carbon double bonds, e.g. those present in unsaturated or polyunsaturated fatty acids (UFAs and PUFAs respectively) [10-12]. Oxidation of PUFAs by O<sub>3</sub> gives rise to the generation of fatty acid ozonides which, on fragmentation, produce aldehydic adducts, the latter putatively serving as ‘biomarkers’ of O<sub>3</sub>-induced cell and tissue damage and, more specifically, UFA ozonation. Indeed, the reactions of O<sub>3</sub> with human skin lipids have been implicated as sources of carbonyl, dicarbonyl and hydroxycarbonyl species detectable in indoor air [<xref ref-type="bibr" rid="scirp.18898-ref13">13</xref>].</p><p>Intriguingly, reaction of water-soluble, single electrondonors with O<sub>3</sub> primarily generates the ozone radical anion (<img src="7-3700135\c6f6ba24-60b8-4ff3-afee-0b66e77e092b.jpg" />), a transient adduct which, on protonation, decomposes to hydroxyl radical (<img src="7-3700135\67c49427-abd5-410c-9e2a-de06d9735b62.jpg" />) and dioxygen. Hence, selected reaction products which putatively arise from the interactions of O<sub>3</sub> with biomolecules present in human tissues and biofluids are identical to those which can be generated from the attack of <img src="7-3700135\59e5c65b-9f68-41c6-9eb3-c3ff9fadd634.jpg" /> radical on such biomolecular scavengers of this ‘Reactive Oxygen Species’ (ROS).</p><p>In view of the clear indications for the therapeutic application of O<sub>3</sub> in the treatment of selected oral diseases, a series of clinical trials involving this agent have recently been completed (e.g. [<xref ref-type="bibr" rid="scirp.18898-ref7">7</xref>]). Moreover, during its therapeutic application, this therapeutic oxidant can gain access to oral fluids such as human saliva, and hence it is of much importance to monitor its reactivity with biomolecules present in this (and other) biofluids (particularly electron-donors), and the products derived from such reactions. Therefore, in this investigation we have performed an evaluation of the oxidising actions of O<sub>3</sub> (generated by a therapeutic device for clinical dental treatment) towards a series of biomolecules present in the oral environment. For this purpose, we have employed high resolution proton (<sup>1</sup>H) nuclear magnetic resonance (NMR) spectroscopy to determine the nature and extent of the oxidation of biomolecules which are known to be present in oral fluids such as human saliva [<xref ref-type="bibr" rid="scirp.18898-ref2">2</xref>] and gingival crevicular fluid (and also in carious dentin and plaque matrices) by O<sub>3</sub>.</p><p>L-methionine and L-cysteine were chosen as model, electron-donating amino acids for these studies since they are present in many salivary proteins and, subsequent to the bacterially-induced proteolysis of such macromolecules, act as precursors to volatile sulphur compounds (VSCs) which predominantly give rise to halitosis (oral malodour). The major VSCs produced in this manner comprise hydrogen sulphide (H<sub>2</sub>S), dimethyl disulphide (CH<sub>3</sub>S-SCH<sub>3</sub>) and methyl mercaptan (CH<sub>3</sub>SH), the latter accounting for approximately 60% of the total VSCs detectable [<xref ref-type="bibr" rid="scirp.18898-ref14">14</xref>].</p><p>The therapeutic and biochemical significance of the results acquired, particularly the ability of salivary biomolecules to protect against the oxidising actions of this agent (i.e. that which may “escape” from its therapeutic application site) are discussed in detail.</p></sec><sec id="s2"><title>2. Materials and Methods</title><sec id="s2_1"><title>2.1. Materials</title><p>Sodium pyruvate, L-methionine, L-cysteine, L-cystine, α-D-glucose, sodium trimethylsilyl-[2,2,3,3-<sup>2</sup>H<sub>4</sub>] propionate (TSP) and deuterium oxide (<sup>2</sup>H<sub>2</sub>O) were of the highest possible analytical grade and purchased from the Sigma-Aldrich Chemical Co. (Gillingham, Dorset, UK).</p></sec><sec id="s2_2"><title>2.2. Sample Preparation and Treatment</title><p>Aqueous solutions containing sodium pyruvate, alpha-Dglucose, L-cysteine and L-methionine (5.00 mM) were prepared in 40.0 mM phosphate buffer (pH 7.00) which was rigorously deoxygenated with O<sub>2</sub>-free N<sub>2</sub> gas prior to use. 5.00 ml aliquots of these aqueous solutions were divided into two equivalent portions (2.50 ml). The first of these was treated with gaseous O<sub>3</sub> synthesised by the HealOzone Unit (CurOzone, USA) for a 10 s period (equivalent to a delivery of 4.84 mmol of this reactive oxygen radical species) and then equilibrated at a temperature of 35˚C for a 60 min. period prior to high-resolution <sup>1</sup>H NMR analysis. The second matching group of de-oxygenated (untreated) 2.50 ml volume solutions, which were equilibrated in the same manner, served as essential controls.</p><p>Each of the above experiments was repeated three times so that there was a total of n = 4 replicate solutions (each with an initial pre-treatment O<sub>3</sub> scavenger concentration of 5.00 mM) for each biomolecule investigated.</p></sec><sec id="s2_3"><title>2.3. <sup>1</sup>H NMR Measurements</title><p>One-dimensional (1D) 600 MHz proton NMR spectra of the chemical model systems described above were acquired on a Bruker AMX-600 spectrometer. Typically, 0.60 ml aliquots of untreated or ozonated biomolecule solutions were treated with a 0.10 ml volume of a 1.47 mM solution of TSP in <sup>2</sup>H<sub>2</sub>O (the latter providing a field-frequency lock), the mixtures thoroughly rotamixed and then transferred to 5-mm diameter NMR tubes. Typical pulsing conditions were: 64 FIDs using 32,768 data points, 72˚ pulses and a 3 s pulse repetition rate to allow full spin-lattice relaxation of the hydrogen nuclei in the samples investigated. Chemical shifts were referenced to TSP (internal; final concentration 0.21 mM), and exponential line-broadening functions of 0.30 Hz were employed for purposes of processing.</p><p>The intensities of the most prominent <sup>1</sup>H NMR resonances of each biomolecule and their corresponding reaction products with O<sub>3</sub> were determined by electronic integration via the spectrometer’s proprietary software (XWIN-NMR), and the concentrations of components detectable were determined by comparisons of their resonance areas with that of the added TSP internal standard (final concentration 0.21 mM). Maintenance of the exact integral regions for each spectrum acquired was ensured.</p></sec><sec id="s2_4"><title>2.4. Spectrophotometric Determination of O<sub>3</sub> in Ozonated Phosphate Buffer Solutions</title><p>The (soluble) O<sub>3</sub> concentration of 40.00 mM phosphate buffer solutions treated with O<sub>3</sub> in the same manner as each of the above biomolecule solutions was determined by a modification of the spectrophotometric method of Schechter [<xref ref-type="bibr" rid="scirp.18898-ref15">15</xref>] which involves the oxidation of iodide anion by O<sub>3</sub> to form the chromophoric <img src="7-3700135\9bbf800d-482a-4186-a462-c16cb8fe1f38.jpg" /> ion (λ<sub>max</sub> = 350 nm, e = 2.32 &#215; 10<sup>4</sup> M<sup>−1</sup>&#183;cm<sup>−1</sup>). Absorbance measurements and electronic absorption spectra were recorded on a Unicam UV-2 spectrophotometer.</p></sec><sec id="s2_5"><title>2.5. Statistical Treatment of Experimental Data</title><p>Results were reported as the mean &#177; between replicates (n = 4) standard error of the mean (SEM) percentage consumption of each biomolecule examined in this study (all pre-treatment biomolecule concentrations were equivalent, i.e. 5.00 mM).</p></sec></sec><sec id="s3"><title>3. Results</title><sec id="s3_1"><title>3.1. Reaction of Pyruvate with O<sub>3</sub></title><p>5.00 mM aqueous solutions of the α-keto acid anion pyruvate were treated with O<sub>3</sub> as described in the Materials and Methods section in order to investigate the redox reaction occurring between these agents, and proton (<sup>1</sup>H) NMR analysis of these solutions demonstrated a marked level of oxidative decarboxylation of this alpha-keto acid anion to acetate and CO<sub>2</sub> (<xref ref-type="fig" rid="fig1">Figure 1</xref>), an observation consistent with the reaction depicted in equation (1). Also consistent with this observation, a singlet resonance located at 1.50 ppm and ascribable to pyruvate hydrate [the enol form of this α-keto acid anion (<img src="7-3700135\5c5fcf80-b712-4a15-b6ba-359303498499.jpg" />)], of much lower intensity than that of the keto form at 2.388 ppm, was also removed from spectra after O<sub>3</sub> treatment. The decreases observed in the intensities of the pyruvate and pyruvate hydrate signals were, of course, accompanied by corresponding equivalent increases in that of the acetate-CH<sub>3</sub> resonance (δ = 1.92 ppm). The mean &#177; SEM percentage decrease in the intensities of the combined pyruvateand pyruvate hydrate-CH<sub>3</sub> signals was found to be 93% &#177; 4% (mean &#177; SEM), although it should be noted that the effective concentration of O<sub>3</sub> in the system employed here is limited by its solubility in water, together with its rate and level of consumption by the scavenger employed, and also its catalytically-promoted dissociation to dioxygen during the 5 min. treatment period.</p><disp-formula id="scirp.18898-formula133742"><label>(1)</label><graphic position="anchor" xlink:href="7-3700135\6c65a34f-9cb0-4c6f-a1d4-f84bfe29aa72.jpg"  xlink:type="simple"/></disp-formula></sec><sec id="s3_2"><title>3.2. Reaction of L-Methionine with O<sub>3</sub></title><p><sup>1</sup>H NMR analysis of reaction products revealed that interaction of O<sub>3</sub> with the thiomethyl group (-S-CH<sub>3</sub>)-containing amino acid L-methionine generated methionine sulphoxide as a major product (<xref ref-type="fig" rid="fig2">Figure 2</xref>), a process consistent with equation (2), where R represents H<sub>3</sub>N<sup>+</sup>CH (<img src="7-3700135\c8a14699-423d-4e6b-bb2a-98a6ae4e5129.jpg" />)CH<sub>2</sub>CH<sub>2</sub>-. Indeed, the -SO-CH<sub>3</sub> protons of this oxidation product has a characteristic singlet resonance located at 2.725 ppm, and it’s concentration is readily monitored by the (relative or normalised) intensity of this signal. Further <sup>1</sup>H NMR signals which were consistent with the generation of methionine sulphoxide were multiplets located at 2.30, 3.02 and 3.85 ppm, which correspond to the β-CH<sub>2</sub>, γ-CH<sub>2</sub> and α-CH protons, respecttively, in this oxidation product. No evidence for the production of methionine sulphone (characteristic-SO<sub>2</sub>- CH<sub>3</sub> singlet resonance located at δ = 3.09 ppm), which may arise from the oxidation of methionine sulphoxide by further O<sub>3</sub>, was provided in these investigations. Under our experimental conditions, the yield of methionine sulphoxide produced was 98% &#177; 4%, i.e. the reaction was essentially complete and quantitative.</p><disp-formula id="scirp.18898-formula133743"><label>(2)</label><graphic position="anchor" xlink:href="7-3700135\7f98c5c7-7540-4dc1-a13d-fcbe065fa3ea.jpg"  xlink:type="simple"/></disp-formula></sec><sec id="s3_3"><title>3.3. Reaction of L-Cysteine with O<sub>3</sub></title><p>L-cysteine was also chosen for these chemical model system experiments since we have been unable to detect this thiol in human saliva by <sup>1</sup>H NMR analysis in view of its low concentration in the “free” (non-protein-incorporated) state, and also its complex ABX coupling pattern (i.e., no clearly-visible sharp resonances of low multiplicity). <sup>1</sup>H NMR analysis demonstrated that exposure of aqueous solutions of this biomolecule [with its characteristic ABX coupling pattern of resonances centred at 3.02 and 3.10 ppm (AB protons) and 3.97 ppm (X proton)] to O<sub>3</sub> (Section 2) generated its corresponding disulphide, cystine, as a major product (data not shown). Indeed, a reference spectrum acquired on an authentic sample of L-cystine confirmed its identity (clear 4-line</p><p>multiplet signals located at 3.20 and 3.41 ppm (AB protons), and a further one at 4.14 ppm (X proton)). Electronic integration of the L-cysteine and cystine resonances demonstrated that 95% &#177; 6% of the former O<sub>3</sub> scavenger was oxidatively transformed to the latter oxidation product. No evidence for the generation of cysteine’s higher oxidation products (such as cysteic acid) was obtained.</p><p>These observations are explicable by the stepwise processes described in equations (3)-(5), i.e. deprotonation of the thiol followed by transfer of an electron from the thiolate anion (RS<sup>−</sup>) to O<sub>3</sub>, and then combination of two thiyl radicals (<img src="7-3700135\81011800-3780-4481-a9c1-f1ef473d50fb.jpg" />, generated in the reaction depicted in equation (4)) to produce cystine (represented as RSSR, where R = H<sub>3</sub>N<sup>+</sup>CH(<img src="7-3700135\fb8e90fe-c574-4e24-ab05-c7aa47c378e1.jpg" />)CH<sub>2</sub>-).</p><disp-formula id="scirp.18898-formula133744"><label>(3)</label><graphic position="anchor" xlink:href="7-3700135\ec67e5a7-04b5-4fc2-ac2d-fd894aa005d1.jpg"  xlink:type="simple"/></disp-formula><disp-formula id="scirp.18898-formula133745"><label>(4)</label><graphic position="anchor" xlink:href="7-3700135\78a38140-64ca-4b7e-821b-215291bae282.jpg"  xlink:type="simple"/></disp-formula><disp-formula id="scirp.18898-formula133746"><label>(5)</label><graphic position="anchor" xlink:href="7-3700135\9ddc1d9c-58fa-49fb-b2b4-3e5b287641fe.jpg"  xlink:type="simple"/></disp-formula><p>However, it should be noted that the aggressivelypowerful oxidant hydroxyl radical (<img src="7-3700135\d5e0a380-6df0-4c73-ba24-a4a8471606d6.jpg" />) can arise from protonation of the <img src="7-3700135\797ec16e-d8fc-4cf8-a1f1-ccf6d88c636f.jpg" /> species followed by decomposition of the resulting <img src="7-3700135\3c620038-155d-4700-a510-5d9f4b0224d2.jpg" /> radical adduct (equations (6) and (7)). The <img src="7-3700135\ac10d00c-132f-41a5-a6b5-86a2518f165b.jpg" /> radical generated in this manner can then</p><disp-formula id="scirp.18898-formula133747"><label>(6)</label><graphic position="anchor" xlink:href="7-3700135\aeacb251-8d0d-48fe-8964-c0707837544d.jpg"  xlink:type="simple"/></disp-formula><disp-formula id="scirp.18898-formula133748"><label>(7)</label><graphic position="anchor" xlink:href="7-3700135\fbf586ca-97fa-4a41-b660-3218bb3b7724.jpg"  xlink:type="simple"/></disp-formula><p>also serve to oxidise L-cysteine to cystine via the prior abstraction of an electron from the thiolate anion (equation (8)), a process again forming thiyl radicals which then also combine to yield the corresponding disulphide (equation (5)).</p><disp-formula id="scirp.18898-formula133749"><label>(8)</label><graphic position="anchor" xlink:href="7-3700135\cb94bf2e-caa4-4e9a-917f-14ccf15b9577.jpg"  xlink:type="simple"/></disp-formula></sec><sec id="s3_4"><title>3.4. Reaction of α-D-Glucose with O<sub>3</sub></title><p><sup>1</sup>H NMR analysis also showed that treatment of phosphate-buffered aqueous solutions of α-D-glucose with O<sub>3</sub> in the manner described in Section 2 generated formate as a major reaction product (identified as singlet <sup>1</sup>H NMR resonance located at δ = 8.46 ppm, <xref ref-type="fig" rid="fig3">Figure 3</xref>), an obser-</p><p>vation consistent with previous studies conducted on the interactions of ROS (particularly radiolytically-generated <img src="7-3700135\7146fcae-87be-4fec-9c25-6b1a7874a328.jpg" /> radical) with carbohydrates in general [<xref ref-type="bibr" rid="scirp.18898-ref16">16</xref>]. A mean &#177; SEM formate concentration of 1.21 &#177; 0.11 mM (representing a 24% &#177; 2% yield of this oxidation product) was produced from the 5.00 mM glucose substrate solution.</p></sec></sec><sec id="s4"><title>4. Discussion</title><sec id="s4_1"><title>4.1. O<sub>3</sub> Scavenging Capacities of the Biomolecules Tested</title><p>The differences observed in the oxidising capacity of O<sub>3</sub> towards pyruvate, methionine, cysteine and α-glucose can be rationalised in terms of the relative scavenging efficacies of these antioxidants tested (L-methionine ≈ L-cysteine ≈ pyruvate &gt; α-D-glucose). Also of much importance for consideration is their mean salivary (or alternative oral fluid or tissue) concentrations. Indeed, for human saliva, these mean values are in the order pyruvate/pyruvate hydrate (1.67 mM [<xref ref-type="bibr" rid="scirp.18898-ref2">2</xref>]) &gt;&gt; methionine (mean pre-O<sub>3</sub> treatment salivary level 274 &#181;M, a value estimated from the data acquired in this investigation) &gt;&gt; cysteine (mean concentration 32 &#181;M [<xref ref-type="bibr" rid="scirp.18898-ref17">17</xref>]): the glucose concentration of this particular oral fluid is highly variable, but little or none of it is detectable by <sup>1</sup>H NMR analysis of samples collected following an 8 hr. overnight fasting episode [<xref ref-type="bibr" rid="scirp.18898-ref2">2</xref>].</p><p>When expressed relative to tryptophan, the rate constants for the reaction of O<sub>3</sub> with methionine, cysteine, and glutathione were found to be 0.77 &#177; 0.08, 0.88 &#177; 0.19 and 0.42 &#177; 0.01 respectively [<xref ref-type="bibr" rid="scirp.18898-ref8">8</xref>] (these relative rate constants correspond to O<sub>3</sub> rather than scavenger consumption). Hence, cysteine reacts with O<sub>3</sub> at a very similar rate to that of methionine, although it is clear that in human saliva, the latter thioether will serve as a much more effective O<sub>3</sub> scavenger than the former thiol in view of its much higher concentration therein (approximately 10-fold greater).</p></sec><sec id="s4_2"><title>4.2. Therapeutic Relevance of the Results Acquired</title><p>The oxidative decarboxylation of pyruvate by O<sub>3</sub> provides a mechanistic example of the therapeutic actions exertable by the latter therapeutic agent (e.g. its caries-preventative, cariostatic and further therapeutic properties). Indeed, pryruvic acid is an extremely powerful organic acid (proton donor) since it has a pK<sub>a</sub> value of 3.20 mM, and therefore is much more powerful than lactic acid (K<sub>a</sub> = 0.14 mM) in this context [<xref ref-type="bibr" rid="scirp.18898-ref18">18</xref>]. Indeed, we have previously noted that pyruvic acid may play a significant role in the facilitation of enamel erosion and tooth demineralisation processes [<xref ref-type="bibr" rid="scirp.18898-ref19">19</xref>], and its removal in human saliva, alternative oral fluids, carious dentin and/or plaque by O<sub>3</sub> may serve to inhibit the induction or further development of primary root caries lesions, especially since salivary organic acids in their unionised forms readily diffuse into tooth enamel [<xref ref-type="bibr" rid="scirp.18898-ref20">20</xref>].</p><p>The oxidative removal of the amino acids methionine and cysteine (both of which are detectable in human saliva, the former by <sup>1</sup>H NMR analysis) by O<sub>3</sub> represents an observation of some significance in relation to both oral hygiene and clinical periodontology, since hydrogen sulphide (H<sub>2</sub>S) and methyl mercaptan (CH<sub>3</sub>SH) are produced from these agents via the metabolic pathways of gram-negative bacteria. Indeed, the enzyme cystine reductase reduces cystine to cysteine, and serine sulphydrase gives rise to the desulphydration of cysteine, a process generating H<sub>2</sub>S and serine [21,22]. Therefore, data acquired here also provide evidence that O<sub>3</sub> may have the ability to clinically suppress oral malodour via the direct oxidative consumption of VSCs and/or their particular amino acid precursors, especially if applied in the form of an O<sub>3</sub>-containing oral rinse system, i.e. ozonated water. In relation to these investigations, in 1992 Grigor and Roberts [<xref ref-type="bibr" rid="scirp.18898-ref17">17</xref>] found that hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) significantly diminished salivary thiol levels both in vivo and in vitro. &#160;</p><p>However, it is also conceivable that the bacterial enzyme cystine reductase may reverse the O<sub>3</sub>-mediated transformation of cysteine to cystine in the oral environment, although it should be noted that O<sub>3</sub> may be present in excess over that of total oral fluid or tissue thiol concentrations, especially when the gaseous concentration is considered along with that present in aqueous solution, the latter level being limited to its solubility in water at physiological temperature, estimates of which are influenced and complicated by that present in the local gas phase and also pH values [<xref ref-type="bibr" rid="scirp.18898-ref23">23</xref>]. However, O<sub>3</sub> determinations in our laboratory performed by a modification of a previously reported method [<xref ref-type="bibr" rid="scirp.18898-ref15">15</xref>] gave a mean concentration of ca. 20 ppm (0.42 mM) when 40.0 mM phosphate buffer solutions (pH 7.00) were treated with this gaseous oxidant under the same experimental conditions as the biomolecule solutions employed for this study (section 2.1), i.e. at ambient temperature and pressure. Hence, a significant fraction of salivary thiols (or those present in alternative oral environments) are expected to be retained in their oxidised (disulphide) forms following reaction with O<sub>3</sub>. Furthermore, it is probable that O<sub>3</sub> has the capacity to oxidatively inactivate bacterially-derived cystine reductase, together with a range of further enzymes available at its site of therapeutic application.</p><p>It is also of much importance to note that methionine is one of only two amino acids encoded by a single codon (AUG) in the standard genetic code (tryptophan, encoded by UGG, is the other) [<xref ref-type="bibr" rid="scirp.18898-ref24">24</xref>]. The codon AUG also represents the “Commencement” message for a ribosome that signals the initiation of protein translation from mRNA. Consequently, methionine is incorporated into the Nterminal position of all proteins in eukaryotes and archaea during translation, although it is usually removed via post-translational modification. This phenomenon is also clearly of much importance to bacteria; however, in this case, the N-formylmethionine derivative is employed as a primary amino acid adduct [<xref ref-type="bibr" rid="scirp.18898-ref25">25</xref>].</p><p>Notwithstanding, it is also important to note that singlet oxygen (<sup>1</sup>O<sub>2</sub>) is also generated in high yield from the reaction of O<sub>3</sub> with a wide range of biomolecules, including the amino acids methionine and cysteine, and the tripeptide glutathione, together with urate, ascorbate, NADH, NADPH and albumin [<xref ref-type="bibr" rid="scirp.18898-ref26">26</xref>] (that involving methionine, which has a thioether group in its side-chain, is depicted in Equation (9)), and therefore this further ROS may also play an important role in perpetuating damage to biomolecules primarily exerted via the actions of O<sub>3</sub>. Indeed, methionine also readily reacts with <sup>1</sup>O<sub>2</sub> to again form its corresponding sulphoxide, a process postulated to involve a highly-reactive persulphoxide intermediate [<xref ref-type="bibr" rid="scirp.18898-ref27">27</xref>] [RS<sup>+</sup>(CH<sub>3</sub>)-O-O<sup>–</sup> in the case of this substrate, where R represents H<sub>3</sub>N<sup>+</sup>CH(<img src="7-3700135\554a78da-dfbc-462c-8059-bae84dac9caa.jpg" />)CH<sub>2</sub>CH<sub>2</sub>-].</p><disp-formula id="scirp.18898-formula133750"><label>(9)</label><graphic position="anchor" xlink:href="7-3700135\13bb32b7-9edd-44d0-bb0e-42736bc6e1e9.jpg"  xlink:type="simple"/></disp-formula><p>Interestingly, for cysteine, the mechanism of cystine generation therefrom has been suggested to involve the reaction of an intermediate sulphoxide species (RSOH) with a second molecule of the cysteine substrate [<xref ref-type="bibr" rid="scirp.18898-ref26">26</xref>] (equation (10)).</p><disp-formula id="scirp.18898-formula133751"><label>(10)</label><graphic position="anchor" xlink:href="7-3700135\173429d6-cc4f-439a-baab-f6f9f27187d8.jpg"  xlink:type="simple"/></disp-formula></sec><sec id="s4_3"><title>4.3. Protective Roles of the Biomolecules Investigated against Adverse Intra-Oral Dissemination of O<sub>3</sub></title><p>All of the metabolites investigated here also serve to act as biomolecular protectants against any adverse or toxic effects exertable by the “leakage” of therapeutically-applied O<sub>3</sub> to soft tissue areas in the oral environment which are or may be accessible by oral fluids containing them (in particular, but not limited to, human saliva). In this manner, these biomolecules have the ability to circumvent any deleterious O<sub>3</sub>-mediated cell and tissue damage potentially arising from this intra-oral dissemination process.</p><p>Indeed, the oxidative modifications of pyruvate, methionine, cysteine and glucose observed here serve as an important examples of the capacity of salivary metabolites to offer protection against any O<sub>3</sub> which diffuses away from its site of application, for example, from primary root carious lesions.</p></sec><sec id="s4_4"><title>4.4. Advantages of <sup>1</sup>H NMR Analysis for Evaluations of the Biomolecular Fate of O<sub>3</sub> in the Oral Environment</title><p>High-resolution, high-field <sup>1</sup>H NMR spectroscopy is a technique which offers many advantages over alternative labour-intensive and onerous analytical methodologies for evaluating the biomolecular fate of O<sub>3</sub> in oral fluids since (1) it permits the rapid, non-invasive and simultaneous examination of a variety of metabolic species and their O<sub>3</sub>-induced oxidation status in chemical model systems, and (2) little or no knowledge of sample composition is required prior to analysis. Moreover, chemical shift values, coupling patterns and coupling constants of resonances present in the <sup>1</sup>H NMR spectra of such model &#160;systems provide much valuable information regarding the molecular nature of oxidation products generated from the interaction of biomolecules with O<sub>3</sub>.</p></sec></sec><sec id="s5"><title>5. Conclusion</title><p>In conclusion, high-resolution <sup>1</sup>H NMR spectroscopy provides much valuable molecular information regarding the nature and extent of oral fluid or tissue biomolecule consumption by O<sub>3</sub>. Such information is clearly of much relevance the potential therapeutic and microbicidal actions of this novel agent in the oral environment, particularly since singlet oxygen (<sup>1</sup>O<sub>2</sub>), which is generated as a by-product of O<sub>3</sub>’s reactions with methionine, cysteine and further biomolecules, can perpetuate oxidative damage to these substrates and hence its microbicidal activity. Furthermore, in view of the large excess of these O<sub>3</sub>- reactive biomolecules over adventitious O<sub>3</sub> in the oral environment, these scavengers are likely to offer remotely-located oral cells and soft tissues protection against any of this oxidant which leaches away from its immediate site of therapeutic application.</p></sec><sec id="s6"><title>REFERENCES</title></sec><sec id="s7"><title>NOTES</title></sec></body><back><ref-list><title>References</title><ref id="scirp.18898-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">D. Beighton, E. Lynch and M. R. Heath, “A Microbiological Study of Primary Root Caries Lesions with Different Treatment Needs,” Journal of Dental Research, Vol. 72, No. 3, 1993, pp. 623-629. 
doi:10.1177/00220345930720031201</mixed-citation></ref><ref id="scirp.18898-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">C. J. L. Silwood, M. C. Grootveld, A. W. D. Claxson and E. Lynch, “1H and 13C NMR Spectroscopic Analysis of Human Saliva,” Journal of Dental Research, Vol. 81, No. 6, 2002, pp. 422-427. doi:10.1177/154405910208100613</mixed-citation></ref><ref id="scirp.18898-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">E. Lynch, “Kariesbehandlung Mit Ozon,” Die Quintessenz, Vol. 54, 2003, pp. 608-610.</mixed-citation></ref><ref id="scirp.18898-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">A. Baysan, R. Whiley and E. Lynch, “Anti-Microbial Effects of a Novel Ozone Generating Device on Micro-Organisms Associated with Primary Root Carious Lesions,” Caries Research, Vol. 34, 2000, pp. 498-501.  
doi:10.1159/000016630</mixed-citation></ref><ref id="scirp.18898-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">A. Baysan, E. Lynch and M. Grootveld, “The Use of Ozone for the Management of Primary Root Caries,” In: T. Albrektsson, D. Bratthall, P. O. Glantz and J. Lindhe, Eds., Tissue Preservation in Caries Treatment, Quintessence Publishing Company Ltd., London, 2001, pp. 49-68.</mixed-citation></ref><ref id="scirp.18898-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">A. Baysan and E. Lynch, “Effect of Ozone on the Oral Microbiota and Clinical Severity of Primary Root Caries,” American Journal of Dentistry, Vol. 17, No. 1, 2004, pp. 56-60. </mixed-citation></ref><ref id="scirp.18898-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">J. Holmes, “Clinical Reversal of Root Caries Using Ozone, Double-Blind, Randomised, Controlled 18-Month Trial,” Gerodontology, Vol. 20, No. 2, 2003, pp. 106-114. 
doi:10.1111/j.1741-2358.2003.00106.x</mixed-citation></ref><ref id="scirp.18898-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">J. R. Kanovsky and P. D. Sima, “Reactive Absorption of Ozone by Aqueous Biomolecule Solutions: Implications for the Role of Sulfhydryl Compounds as Targets for Ozone,” Archives of Biochemistry and Biophysics, Vol. 316, No. 1, 1995, pp. 52-62. doi:10.1006/abbi.1995.1009</mixed-citation></ref><ref id="scirp.18898-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">S. Kermani, A. Ben-Jebria and J. S. Ultman, “Kinetics of Ozone Reaction with Uric Acid, Ascorbic Acid, and Glutathione at Physiologically Relevant Conditions,” Archives of Biochemistry and Biophysics, Vol. 451, No. 1, 2006, pp. 8-16. doi:10.1016/j.abb.2006.04.015</mixed-citation></ref><ref id="scirp.18898-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">T. Thornberry and J. P. D. Abbatt, “Heterogeneous Reaction of Ozone with Liquid Unsaturated Fatty Acids: Detailed Kinetics and Gas-Phase Product Studies,” Physical Chemistry and Chemical Physics, Vol. 6, 2004, pp. 84-93. doi:10.1039/b310149e</mixed-citation></ref><ref id="scirp.18898-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">M. F. Diaz, F. Hernandez, O. Ledea, J. A. Gavin Sazatornil and J. Moleiro, “1H NMR Study of Methyl Linoleate Ozonation,” Ozone: Science &amp; Engineering: The Journal of the International Ozone Association, Vol. 25, No. 2, 2003, pp. 121-126. doi:10.1080/713610666</mixed-citation></ref><ref id="scirp.18898-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">J. J. Thiele, M. G. Traber, T. G. Polefka, C. E. Cross and L. Packer, “Ozone-Exposure Depletes Vitamin E and Induces Lipid Peroxidation in Murine Stratum Corneum,” Journal of Investigative Dermatology, Vol. 108, 1997, pp. 753-757. doi:10.1111/1523-1747.ep12292144</mixed-citation></ref><ref id="scirp.18898-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">A. Wisthaler and C. J. Weschler, “Reactions of Ozone with Human Skin Lipids: Sources of Carbonyls, Dicarbonyls, and Hydroxycarbonyls in Indoor Air,” Proceedings of the National Academy of Sciences, Vol. 107, No. 15, 2010, pp. 6568-6575. doi:10.1073/pnas.0904498106</mixed-citation></ref><ref id="scirp.18898-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">J. Tonzetich, “Direct Gas Chromatographic Analysis of Sulphur Compounds in Mouth Air in Man,” Archives of Oral Biology, Vol. 16, No. 6, 1971, pp. 587-597. 
doi:10.1016/0003-9969(71)90062-8</mixed-citation></ref><ref id="scirp.18898-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">H. Shechter, “Spectrophotometric Method for Determination of Ozone in Water,” Water Research, Vol. 7, No. 5, 1973, pp. 729-729. doi:10.1016/0043-1354(73)90089-4</mixed-citation></ref><ref id="scirp.18898-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">M. Grootveld, E. B. Henderson, A. J. Farrell, D. R. Blake, H. G. Parkes and P. Haycock, “Oxidative Damage to Hyaluronate and Glucose in Synovial Fluid during Exercise of the Inflamed Rheumatoid Joint: Detection of Abnormal Low-Molecular-Mass Metabolities by Proton NMR Spectroscopy,” Biochemical Journal, Vol. 273, No. 2, 1991, pp. 459-467.</mixed-citation></ref><ref id="scirp.18898-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">J. Grigor and A. J. Roberts, “Reduction in the Levels of Oral Malodor Precursors by Hydrogen Peroxide: In Vitro and in Vivo Assessments,” Journal of Clinical Dentistry, Vol. 3, No. 4, 1992, pp. 111-115. </mixed-citation></ref><ref id="scirp.18898-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">A. E. Martell and R. J. Motekaitis. “The Determination and Use of Stability Constants,” VCH Weinham, Hoboken, 1988.</mixed-citation></ref><ref id="scirp.18898-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">C. J. L. Silwood, E. Lynch, S. Seddon, A. Sheerin, A. W. D. Claxson and M. C. Grootveld, “1H-NMR Analysis of Microbial-Derived Organic Acids in Primary Root Carious Lesions and Saliva,” NMR in Biomedicine, Vol. 12, No. 6, 1999, pp. 345-356.  
doi:10.1002/(SICI)1099-1492(199910)12:6&lt;345::AID-NBM580&gt;3.0.CO;2-C</mixed-citation></ref><ref id="scirp.18898-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">J. D. B. Featherstone and B. E. Rodgers, “Effect of Acetic, Lactic and Other Organic Acids on the Formation of Artificial Carious Lesions,” Caries Research, Vol. 15, 1981, pp. 377-385. doi:10.1159/000260541</mixed-citation></ref><ref id="scirp.18898-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">J. Tonzetich and P. A. W. Carpenter, “Production of Volatile Sulphur Compounds from Cysteine, Cysteine and Methionine by Human Dental Plaque,” Archives of Oral Biology, Vol. 16, No. 6, 1971, pp. 599-607.  
doi:10.1016/0003-9969(71)90063-X</mixed-citation></ref><ref id="scirp.18898-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">J. Tonzetich, P.W. Johnson and S. K. Ng, “Pathways of Cystine Metabolism in Human Saliva,” Archives of Oral Biology, Vol. 24, No. 1, 1979, pp. 35-39.  
doi:10.1016/0003-9969(79)90172-9</mixed-citation></ref><ref id="scirp.18898-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">R. Battino, T. R. Rettich and T. Tominaga, “The Solubility of Oxygen and Ozone in Liquids,” Journal of Physical Chemistry Reference Data, Vol. 12, No. 2, 1983, pp. 163-178. doi:10.1063/1.555680</mixed-citation></ref><ref id="scirp.18898-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">A. Bender, et al., “Adaptive Antioxidant Methionine Accumulation in Respiratory Chain Complexes Explains the Use of a Deviant Genetic Code in Mitochondria,” Proceedings of the National Academy of Sciences, Vol. 105, No. 43, 2008, pp. 16496-16501. 
doi:10.1073/pnas.0802779105</mixed-citation></ref><ref id="scirp.18898-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">R. E Thach, K. F. Dewey, J. C. Brown and P. Doty, “Formylmethionine Codon AUG as an Initiator of Polypeptide Synthesis,” Science, Vol. 153, No. 3734, 1966, pp. 416-418. 
doi:10.1126/science.153.3734.416</mixed-citation></ref><ref id="scirp.18898-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">J. R. Kanovsky and P. Sima, “Singlet Oxygen Production from the Reactions of Ozone with Biological Molecules,” Journal of Biological Chemistry, Vol. 266, No. 14, 1990, pp. 9039-9042.</mixed-citation></ref><ref id="scirp.18898-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">R. Bonnett and G. Martinez, “Photobleaching of Sensitisers used in Photodynamic Therapy,” Tetrahedron, Vol. 57, No. 47, 2001, pp. 9513-9547. 
doi:10.1016/S0040-4020(01)00952-8</mixed-citation></ref></ref-list></back></article>